Storytelling Intervention for African Americans Living With Hypertension

Hypertension Clinical Trial

Official title:

Developing and Implementing a Storytelling Intervention for African Americans Living With Hypertension

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05594264
• Other study ID #: 1766419-7
• Status: Recruiting
• Phase: N/A
• Start date: July 14, 2022
• Est. completion date: August 30, 2023

Study information

• Verified date: May 2023
• Source: University of Delaware
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Narrative communication (e.g., storytelling) is an approach that has contributed to behavioral change for individuals with conditions such as diabetes, breast cancer, and hypertension. The objective of this study is to conduct a feasibility and pilot study storytelling intervention for African Americans with hypertension. In the feasibility phase 30 African Americans with hypertension will be recruited to view nine patient stories and provide feedback on the effectiveness, usefulness, and satisfaction with the stories. Nine African Americans adults with hypertension were filmed, sharing experiences living with and managing hypertension; including, diet and exercise tips, suggestions for locating healthy foods, and motivational stories about successfully controlling hypertension. During the feasibility phase feedback will also be elicited from the participants about the best approaches for delivering a storytelling intervention, and obtain feedback on the resources and health information that would be helpful to an individual participating in a storytelling intervention. In the pilot study phase, 30 African Americans adults with hypertension will be recruited to participate in a 6-week trial, each week the participants will watch one story and review one module of health information accessible through the study specific website developed for the HBPStories study. Data will be collected at baseline and 6-weeks including systolic and diastolic blood pressure, medication adherence, health behaviors such as diet and physical activity, and psychosocial measures including positive affect and self-efficacy in the management of hypertension.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 60
• Est. completion date: August 30, 2023
• Est. primary completion date: May 31, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

The study inclusion criteria are as follows:

• self-reported hypertension

• race/ethnicity: Black or African American

• prescribed antihypertensive medication

• age = 18 years

Exclusion Criteria:

The exclusion criteria are:

• cognitive limitations that limit the ability to provide informed consent

• unable to speak or read English

Related Conditions & MeSH terms

• Hypertension

Intervention

Behavioral:
• HBPStories
A 6-week web-based study. Systolic blood pressure, diastolic blood pressure, and medication adherence will be measured at baseline and 6-weeks.

Locations

Country	Name	City	State
United States	University of Delaware	Newark	Delaware

Sponsors (1)

Lead Sponsor	Collaborator
University of Delaware

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Blood Pressure	Systolic and Diastolic Blood Pressure, Unit of Measure: Percentage of Individuals with Elevated or High Blood Pressure	6 weeks
Primary	Medication Adherence	Self-reported using the DOSE-Nonadherence Scale, Unit of Measure: Percentage of Individuals reporting low, moderate, or high adherence	6 weeks
Secondary	Diet	Self-reported using the Assessment of Dietary Adherence and Identification of Barriers to Healthy Eating, Unit of Measure: Percent of participants reporting a healthy diet	6 week
Secondary	Physical Activity	Self-reported using the Yale Physical Activity Scale, Unit of Measure: Rates of physical inactivity	6 week